Latest content
- Novartis breaks ground on US radioligand therapy site
- OVID Health has appointed Davide Scalenghe as Head of Global Strategy & Partnerships
- LEO Pharma to acquire Replay gene therapy platform
- Cue Biopharma appoints Shao-Lee Lin as CEO, President and Director
- Angelini Pharma to acquire Catalyst Pharmaceuticals for $4.1bn